https://www.selleckchem.com/pr....oducts/gsk-j4-hcl.ht
Liquid biopsy tests used to determine eligibility for PARP inhibition among men with advanced prostate cancer are prone to false positives because of interference from clonal hematopoiesis-but analyzing plasma cell-free DNA alongside paired whole-blood control samples can correct this problem.The NCI and Cancer Research UK have launched Cancer Grand Challenges, a $380 million initiative to fund global research on some of the most pressing issues in cancer research. For the first round of funding, the program plans to select up to fou
Like
Comment
Share
